Treating EGFR Mutant NSCLC in Brazil
Podcast | English | 38 Min
Image For Activity Cover
No Credit Offered
This episode of Lung Cancer Considered examines the treatment of EGFR-positive lung cancer in Brazil from early-stage disease to metastatic lung cancer.
  • Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, USA 
  • Victor Marcondes, MD, Thoracic Medical Oncologist, Oncomed Oncologia, Brazil
  • Juliana Ominelli, MD, medical Oncologist, Brazilian National Cancer Institute - Oncologia DASA, Brazil
Powered By